相关实验视频

Updated: Jun 25, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

结肠直肠癌:精准医学的基因基础和分子疗法

Gideon T Dosunmu¹, Ardaman Shergill¹

¹Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

|May 25, 2024

概括

结肠直肠癌 (CRC) 是一个主要的全球健康问题. 本综述探讨了CRC遗传学,重点关注突变和个性化治疗,以获得更好的结果.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
癌症研究癌症研究

背景情况:

结肠直肠癌 (CRC) 代表着全球严重的健康负担,约占全球所有癌症病例的10%,与癌症相关的死亡人数的9%.
在美国,CRC约占癌症诊断的12.6%,死亡率为8%.
值得注意的是,CRC是50岁以下人群癌症死亡的主要原因,这凸显了它对年轻人群的影响越来越大.

研究的目的:

为了审查结直肠癌的遗传情景.
要突出驱动CRC进展和治疗耐药性的关键突变.
提供当前和新兴基因组定制治疗策略的概述.

主要方法:

关于结直肠癌遗传变化的文献综述.
对突变数据及其临床意义的分析.
在CRC中对精准医学方法的信息的综合.

主要成果:

确定影响结直肠癌发展和行为的关键基因突变.
了解这些突变对疾病进展的影响.
基于特定基因组资料的向疗法的概述.

结论:

结直肠癌的遗传构成对于了解其进展至关重要.
针对特定突变的个性化治疗策略为改善CRC治疗提供了有希望的途径.
对CRC遗传情景的进一步研究将推动精密瘤学的进步.

关键词:

结肠直肠癌是什么意思遗传变化遗传变化分子治疗的分子疗法.精准医学是一门精准医学.

更多相关视频

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...